On the basis of our previous results and other identified cytoskeletal and exocytotic functions of MYO9A, here our hypothesis was that MYO9A disrupts NMJ function in CMS by affecting the neuronal cytoskeleton, thus impacting on vesicular trafficking and protein secretion. Here, MYO9A is linked to congenital myasthenic syndrome.